Subtype
Childhood Benign Connective and Soft Tissue Neoplasm
CI-CAN-00000679Explore in graph →
PediatricNon-malignant2 active trials
- NCIt
- C190576
Loading cancer entity…
Subtype
CI-CAN-00000679Explore in graph →
Clinical trials
21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06677853 | Timolol Maleate Gel for the Treatment of Infantile Hemangioma | completed | Phase 2 / Phase 3 | 168 | Auson Pharmaceuticals Inc.INDUSTRY | 1 | Nov 7, 2024 | clinicaltrials |
| NCT02505971 | Nadolol Versus Propranolol in Children With Infantile Hemangiomas | completed | Phase 3 | 74 | The Hospital for Sick ChildrenOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy |
| completed |
| Phase 2 / Phase 3 |
| 512 |
| Pierre Fabre DermatologyINDUSTRY |
| 16 |
| Dec 10, 2015 |
| clinicaltrials |
Data updated 22 days agoSource updated Nov 7, 2024source: clinicaltrials